Outlook Therapeutics Inc (OTLK)
7.78
+0.45
(+6.14%)
USD |
NASDAQ |
May 17, 16:00
7.78
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.90M |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -0.00 |
| June 30, 2019 | -0.1507M |
| March 31, 2019 | -0.0501M |
| December 31, 2018 | -0.2364M |
| September 30, 2018 | -1.263M |
| June 30, 2018 | -0.168M |
| March 31, 2018 | -0.2752M |
| December 31, 2017 | -1.075M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.024M |
| June 30, 2017 | -0.0762M |
| March 31, 2017 | -0.0435M |
| December 31, 2016 | -0.1484M |
| September 30, 2016 | -0.3284M |
| June 30, 2016 | -0.4525M |
| March 31, 2016 | 0.0469M |
| December 31, 2015 | -0.3642M |
| September 30, 2015 | -3.294M |
| June 30, 2015 | -3.489M |
| March 31, 2015 | -1.493M |
| December 31, 2014 | -0.5279M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.90M
Minimum
Jun 2020
--
Maximum
Sep 2020
-0.2627M
Average
-0.0754M
Median
Cash from Investing (Quarterly) Benchmarks
| Cutera Inc | -0.278M |
| Actinium Pharmaceuticals Inc | -0.011M |
| GT Biopharma Inc | 0.478M |
| Karyopharm Therapeutics Inc | 21.94M |
| Marinus Pharmaceuticals Inc | 20.88M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.27M |
| Cash from Financing (Quarterly) | 56.14M |
| Free Cash Flow | -58.26M |
| Free Cash Flow Per Share (Quarterly) | -1.350 |
| Free Cash Flow Yield | -56.37% |